Astrana Health (NASDAQ:ASTH) Price Target Raised to $47.00

Astrana Health (NASDAQ:ASTH) had its price target upped by analysts at Truist Financial from $38.00 to $47.00 in a report released on Thursday,Benzinga reports. The firm currently has a “buy” rating on the stock. Truist Financial’s price objective would indicate a potential upside of 19.61% from the company’s current price.

ASTH has been the subject of a number of other reports. Weiss Ratings raised shares of Astrana Health from a “sell (d+)” rating to a “hold (c-)” rating in a research note on Wednesday, April 29th. Robert W. Baird set a $45.00 price target on shares of Astrana Health in a research note on Friday, May 8th. TD Cowen upped their price target on shares of Astrana Health from $35.00 to $45.00 and gave the stock a “buy” rating in a research note on Tuesday. Barclays upped their price target on shares of Astrana Health from $26.00 to $37.00 and gave the stock an “equal weight” rating in a research note on Monday. Finally, BTIG Research upped their price target on shares of Astrana Health from $40.00 to $50.00 and gave the stock a “buy” rating in a research note on Friday, May 8th. Six research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company’s stock. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average target price of $43.14.

Astrana Health Stock Performance

Astrana Health stock traded down $0.47 during midday trading on Thursday, reaching $39.30. 41,316 shares of the stock traded hands, compared to its average volume of 517,443. The company has a current ratio of 1.35, a quick ratio of 1.40 and a debt-to-equity ratio of 1.20. The firm has a fifty day moving average price of $28.75 and a two-hundred day moving average price of $25.84. The firm has a market cap of $2.19 billion, a price-to-earnings ratio of 64.19 and a beta of 0.98. Astrana Health has a fifty-two week low of $18.08 and a fifty-two week high of $39.93.

Astrana Health (NASDAQ:ASTH) last issued its quarterly earnings results on Thursday, May 7th. The company reported $0.74 earnings per share for the quarter, topping analysts’ consensus estimates of $0.29 by $0.45. The company had revenue of $965.10 million during the quarter, compared to analyst estimates of $949.21 million. Astrana Health had a net margin of 0.86% and a return on equity of 9.22%. The business’s revenue for the quarter was up 55.6% compared to the same quarter last year. During the same period in the prior year, the business posted $0.42 EPS. On average, equities research analysts forecast that Astrana Health will post 1.25 earnings per share for the current year.

Institutional Trading of Astrana Health

Institutional investors have recently made changes to their positions in the stock. 325 Capital LLC increased its stake in Astrana Health by 54.0% in the 4th quarter. 325 Capital LLC now owns 1,839,076 shares of the company’s stock valued at $45,627,000 after buying an additional 645,123 shares during the period. State Street Corp increased its stake in Astrana Health by 6.2% in the 4th quarter. State Street Corp now owns 1,675,516 shares of the company’s stock valued at $41,570,000 after buying an additional 98,064 shares during the period. Dimensional Fund Advisors LP increased its stake in Astrana Health by 12.5% in the 1st quarter. Dimensional Fund Advisors LP now owns 1,368,079 shares of the company’s stock valued at $33,545,000 after buying an additional 152,267 shares during the period. Geode Capital Management LLC increased its stake in Astrana Health by 1.2% in the 4th quarter. Geode Capital Management LLC now owns 1,028,168 shares of the company’s stock valued at $25,513,000 after buying an additional 12,212 shares during the period. Finally, Wellington Management Group LLP increased its stake in Astrana Health by 418.3% in the 4th quarter. Wellington Management Group LLP now owns 738,853 shares of the company’s stock valued at $18,331,000 after buying an additional 596,293 shares during the period. 52.77% of the stock is currently owned by institutional investors and hedge funds.

About Astrana Health

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients. It offers care coordination services to patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans.